Delayed-type cutaneous drug hypersensitivity is a T-cell mediated disease; the spectrum of conditions has been classified according to the phenotype and function of drug antigen-specific T-cells sub-sets. Importantly, this classification does not take into account tissue-specific cytokines such as interleukin-17 and interleukin-22. Both of these cytokines have been shown to play a role in numerous physiological and pathological processes. For example, elevated levels have been detected in patients with psoriasis and allergic contact dermatitis. To investigate this, we have focused on piperacillin, a beta-lactam antibiotic used for the treatment of pulmonary exacerbations in patients with cystic fibrosis. Unfortunately hypersensitivity reactions (mean onset = 9.1 days; symptoms include maculopapular rash, fever and/or flu-like symptoms) to this drug develop in 26-50% of treated patients. Piperacillin-specific T-cell clones were generated from 3 lymphocyte transformation test positive hypersensitive patients and 4 healthy donors, following priming of naive T-cells against piperacillin-exposed dendritic cells, to characterize T-cell phenotype (CD and chemokine receptor expression) and function (proliferation and secretion of cytokines/cytolytic molecules [IFNgamma, 13, 17, 22 by ELIspot]). Seventy six CD4+ and CD8+ clones were isolated from the hypersensitive patients and shown to proliferate in the presence of piperacillin. Drug stimulation was associated with the secretion of IFN-gamma and IL13 from all clones. IL-22 secretion was detected from 64% and 75% of the CD4+ and CD8+ clones, respectively. In contrast, IL17 was not detected. Naive T-cells co-cultured with piperacillin and autologous dendritic cells showed concentration-dependent proliferation and cytokine (IFNgamma, IL13 and IL22) secretion. CD4+ and CD8+ clones generated from the primed T-cells also secreted IFNgamma, IL13 and IL22 (CD4+ 50%, CD8+ 67%) following piperacillin stimulation. CCR1, CCR4 and CCR10 were expressed on all clones. Other chemokine receptors expressed on a limited number of clones included CXCR3, CXCR6, CCR2 and CCR9. In conclusion, these data show the involvement of IL22 secreting T-cells in the pathogenesis of piperacillin hypersensitivity reactions in patients with cystic fibrosis.
CITATION STYLE
Sullivan, A., Wang, E., Farrell, J., Whitaker, P., Peckham, D., Park, B. K., & Naisbitt, D. (2014). Detection of interleukin‐22 secreting T‐cells in piperacillin hypersensitive patients with cystic fibrosis. Clinical and Translational Allergy, 4(S3). https://doi.org/10.1186/2045-7022-4-s3-p108
Mendeley helps you to discover research relevant for your work.